The true test of the stock (not the company) will be holding above $1 with an active short Noramco trying to protect his very vulnerable position.
If buying comes in from private equity/hedge funds and investors...in sufficient volume...and sustained...you will see your questions and (prayers) answered...
...otherwise it will be continuous battle until a substantial revenue adoption of G2 is made...but that should be a matter of time not if...IMHO.
News 
Market Data 
Discover 
